The CHEK2 del5395 is a founder mutation without direct effects for cancer risk in the latvian population

por Plonis, J, Kalniete, D, Nakazawa-Miklasevica, M, Irmejs, A, Vjaters, E, Gardovskis, J, Miklasevics, E
Publicado 2016

High frequency of pathogenic non-founder germline mutations in BRCA1 and BRCA2 in families with breast and ovarian cancer in a founder population

por Maksimenko, J., Irmejs, A., Trofimovičs, G., Bērziņa, D., Skuja, E., Purkalne, G., Miklaševičs, E., Gardovskis, J.
Publicado 2018

A novel frequent BRCA1 recurrent variant c.5117G > A (p.Gly1206Glu) identified after 20 years of BRCA1/2 research in the Baltic region: cohort study and literature review

por Loza, P., Irmejs, A., Daneberga, Z., Miklasevics, E., Berga-Svitina, E., Subatniece, S., Maksimenko, J., Trofimovics, G., Tauvena, E., Ukleikins, S., Gardovskis, J.
Publicado 2021